On Sept. 5, 2025, the U.S. Food and Drug Administration (FDA) approved Inlexzo (gemcitabine intravesical system) for adults ...
Patients with muscle-invasive bladder cancer who test positive for circulating tumor (ct)DNA after surgery to remove the ...
Deion Sanders said he thinks has more blood clots due to experiencing leg pain after recently being treated for bladder cancer.
The FDA accepted an application for Padcev plus Keytruda for patients with muscle-invasive bladder cancer ineligible for ...
Tecentriq reduced the risk of death by 41% and the risk of disease recurrence or death by 36% compared with placebo –– ...
A HALF-HOUR scan could nearly halve bladder cancer deaths, a study suggests. Giving patients an MRI scan before the usual biopsy helps doctors start treatment faster, boosting survival chances. It ...
The pioneering study uses a new approach to detect the presence of circulating tumour DNA (ctDNA) to accurately identify ...
The Dana-Farber-co-led phase 3 IMvigor011 trial results show that periodic ctDNA screening after surgery can help guide a ...
The pioneering study uses a new approach to detect the presence of circulating tumour DNA (ctDNA) to accurately identify which patients with ...
The health journey of NFL legend and University of Colorado head coach Deion Sanders has become more than a personal battle - ...
Enfortumab vedotin and pembrolizumab with surgery significantly improve outcomes in cisplatin-ineligible MIBC patients, reducing disease progression or death risk by 60%. The EV-303/KEYNOTE-905 trial ...
In patients with early-stage HER2-positive breast cancer in the DESTINY-Breast 05 and the DESTINY-Breast 11 trials, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback